New hope for arthritis sufferers: experimental drug BGB-45035 in Late-Stage trial

NCT ID NCT07100938

First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 28 times

Summary

This study tests an experimental drug called BGB-45035 in adults with moderate to severe rheumatoid arthritis who haven't gotten enough relief from standard treatments. About 49 participants will receive either the drug or a placebo to see if it reduces joint pain and swelling. The goal is to better control the disease, not cure it.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Affiliated Hospital of Liaoning University of Traditional Chinese Medicine

    Shenyang, Liaoning, 110000, China

  • Affiliated Hospital of Nantong University

    Nantong, Jiangsu, 201203, China

  • Affiliated Hospital of North Sichuan Medical College

    Nanchong, Sichuan, 637000, China

  • Anhui Provincial Hospital

    Hefei, Anhui, 230000, China

  • Beijing Friendship Hospital, Capital Medical University

    Beijing, Beijing Municipality, 100050, China

  • Chenzhou No1 Peoples Hospital

    Chenzhou, Hunan, 423000, China

  • Huashan Hospital Fudan University

    Shanghai, Shanghai Municipality, 200040, China

  • Nanfang Hospital, Southern Medical University

    Guangzhou, Guangdong, 510515, China

  • Nanjing Drum Tower Hospital,the Affiliated Hospital of Nanjing University Medical School

    Nanjing, Jiangsu, 210008, China

  • Nanyang Central Hospital

    Nanyang, Henan, 473000, China

  • Northern Jiangsu Peoples Hospital

    Yangzhou, Jiangsu, 225001, China

  • Peking University First Hospital

    Beijing, Beijing Municipality, 100034, China

  • Pingxiang Peoples Hospital

    Pingxiang, Jiangxi, 337055, China

  • Sichuan Academy of Medical Sciences and Sichuan Provincial Peoples Hospital

    Chengdu, Sichuan, 610071, China

  • Sun Yat Sen Memorial Hospital, Sun Yat Sen University (North)

    Guangzhou, Guangdong, 510000, China

  • The Affiliated Hospital of Inner Mongolia Medical University

    Hohhot, Inner Mongolia, 010050, China

  • The First Affiliated Hospital of Bengbu Medical University

    Bengbu, Anhui, 233004, China

  • The First Affiliated Hospital of Guangxi Medical University

    Nanning, Guangxi, 530021, China

  • The First Affiliated Hospital of Henan University of Science and Technology

    Luoyang, Henan, 471003, China

  • The First Affiliated Hospital of Nanchang University Branch Donghu

    Nanchang, Jiangxi, 330006, China

  • The First Affiliated Hospital of Xian Jiaotong University

    Xi'an, Shaanxi, 710061, China

  • The First Affiliated Hospital, Sun Yat Sen University

    Guangzhou, Guangdong, 510080, China

  • The First Hospital of Jilin University

    Changchun, Jilin, 130021, China

  • The First Peoples Hospital of Changzhou

    Changzhou, Jiangsu, 213000, China

  • The Second Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, 400010, China

  • The Second Affiliated Hospital of Harbin Medical University

    Harbin, Heilongjiang, 150001, China

  • The Second Affiliated Hospital of Zhejiang University School of Medicine

    Hangzhou, Zhejiang, 310009, China

  • The Second Xiangya Hospital of Central South University

    Changsha, Hunan, 410011, China

  • Zhengzhou Central Hospital

    Zhengzhou, Henan, 450007, China

Conditions

Explore the condition pages connected to this study.